Godavari Drugs Limited (BOM:530317)
India
· Delayed Price · Currency is INR 82.89
+2.60 (3.24%)
At close: Mar 10, 2026
Godavari Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 43.8 | 55.49 | 37.86 | 52.45 | 41.28 | Upgrade
|
| Depreciation & Amortization | - | 24.48 | 24.48 | 19.44 | 16.96 | 12.23 | Upgrade
|
| Other Operating Activities | - | 38.45 | 42.01 | 31.94 | 25.73 | 28.98 | Upgrade
|
| Change in Accounts Receivable | - | 171 | -14.88 | -23.56 | -104.58 | -91.03 | Upgrade
|
| Change in Inventory | - | -72.91 | -7.95 | -98.22 | 46.16 | 31.02 | Upgrade
|
| Change in Other Net Operating Assets | - | -92.85 | 85 | 164.72 | 75.57 | -9.2 | Upgrade
|
| Operating Cash Flow | - | 111.96 | 184.14 | 132.17 | 112.3 | 13.28 | Upgrade
|
| Operating Cash Flow Growth | - | -39.20% | 39.32% | 17.70% | 745.75% | -78.73% | Upgrade
|
| Capital Expenditures | - | -199.98 | -132.01 | -93.36 | -52.45 | -16.72 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 1.88 | 1.48 | - | - | Upgrade
|
| Other Investing Activities | - | 4.86 | -2.08 | 5.49 | 2.74 | 4.22 | Upgrade
|
| Investing Cash Flow | - | -195.12 | -132.22 | -86.39 | -49.71 | -12.5 | Upgrade
|
| Long-Term Debt Issued | - | 127.28 | - | 1.65 | - | 33.26 | Upgrade
|
| Total Debt Issued | - | 127.28 | - | 1.65 | - | 33.26 | Upgrade
|
| Long-Term Debt Repaid | - | - | -7.8 | - | -27.08 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 127.28 | -7.8 | 1.65 | -27.08 | 33.26 | Upgrade
|
| Other Financing Activities | - | -46.61 | -48.74 | -39.36 | -29.13 | -31.92 | Upgrade
|
| Financing Cash Flow | - | 80.67 | -56.54 | -37.7 | -56.21 | 1.34 | Upgrade
|
| Net Cash Flow | - | -2.5 | -4.62 | 8.08 | 6.38 | 2.12 | Upgrade
|
| Free Cash Flow | - | -88.02 | 52.12 | 38.81 | 59.85 | -3.44 | Upgrade
|
| Free Cash Flow Growth | - | - | 34.30% | -35.15% | - | - | Upgrade
|
| Free Cash Flow Margin | - | -7.71% | 3.31% | 2.43% | 3.71% | -0.28% | Upgrade
|
| Free Cash Flow Per Share | - | -11.70 | 6.92 | 5.16 | 7.95 | -0.46 | Upgrade
|
| Cash Interest Paid | - | 47.32 | 49.15 | 39.27 | 28.49 | 33.08 | Upgrade
|
| Cash Income Tax Paid | - | 11.55 | 10.17 | 12.27 | 12.27 | 11.88 | Upgrade
|
| Levered Free Cash Flow | - | -72.71 | -12.12 | -336.51 | 67.61 | -38.11 | Upgrade
|
| Unlevered Free Cash Flow | - | -43.14 | 18.6 | -311.97 | 85.42 | -18.18 | Upgrade
|
| Change in Working Capital | - | 5.24 | 62.17 | 42.94 | 17.15 | -69.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.